ordinary shares and the exercise ratio to purchase the ordinary shares, including the method to calculate the said adjustments, as described hereinafter shall not subordinate any returns, which the warrant

described hereinafter shall not subordinate any returns, which the warrant holders or warrant substitute holders will receive once they exercise their rights under warrant or warrant substitute. However

purchase the ordinary shares and the exercise ratio to purchase the ordinary shares, including the method to calculate the said adjustments, as described hereinafter shall not subordinate any returns, which

of capital increase from the Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 1st quarter

income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural

million or 438.9%. The most of transaction causing from the operational performance from subsidiary company which was fully operational in March 2019, and experiencing accumulated loss. Net Profits For the

baht. 92.65 percent because in the quarter 2 years 2016. The company profits from the sale to a third party the amount of 10.60 million baht. 4. Other income 3.35 million baht Decrease from the same

Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 2nd quarter of Year 2017 and 2018, the net

returns in the form of cash flows from long-term operations (Mismatch Funding). Therefore, the financial restructuring by issuing and offering new shares for this capital increase therefore is a source of

from the same period of previous year by gaining the profits from the sales of empty land located at the Bhumibol Bridge. Paid interest was 0.28 million baht. It decreased from previous year amount to